235 related articles for article (PubMed ID: 36645496)
1. Novel neuroactive steroids as positive allosteric modulators of NMDA receptors: mechanism, site of action, and rescue pharmacology on GRIN variants associated with neurological conditions.
Tang W; Beckley JT; Zhang J; Song R; Xu Y; Kim S; Quirk MC; Robichaud AJ; Diaz ES; Myers SJ; Doherty JJ; Ackley MA; Traynelis SF; Yuan H
Cell Mol Life Sci; 2023 Jan; 80(2):42. PubMed ID: 36645496
[TBL] [Abstract][Full Text] [Related]
2. Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.
Tang W; Liu D; Traynelis SF; Yuan H
Neuropharmacology; 2020 Oct; 177():108247. PubMed ID: 32712275
[TBL] [Abstract][Full Text] [Related]
3. The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors.
Paul SM; Doherty JJ; Robichaud AJ; Belfort GM; Chow BY; Hammond RS; Crawford DC; Linsenbardt AJ; Shu HJ; Izumi Y; Mennerick SJ; Zorumski CF
J Neurosci; 2013 Oct; 33(44):17290-300. PubMed ID: 24174662
[TBL] [Abstract][Full Text] [Related]
4. Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis.
Mannara F; Radosevic M; Planagumà J; Soto D; Aguilar E; García-Serra A; Maudes E; Pedreño M; Paul S; Doherty J; Quirk M; Dai J; Gasull X; Lewis M; Dalmau J
Brain; 2020 Sep; 143(9):2709-2720. PubMed ID: 32830245
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of SAGE-718, a novel positive allosteric modulator of N-methyl-d-aspartate receptors.
Beckley JT; Aman TK; Ackley MA; Kazdoba TM; Lewis MC; Smith AC; Farley BJ; Dai J; Deats W; Hoffmann E; Robichaud AJ; Doherty JJ; Quirk MC
Br J Pharmacol; 2024 Apr; 181(7):1028-1050. PubMed ID: 37698384
[TBL] [Abstract][Full Text] [Related]
6. Pregnane-based steroids are novel positive NMDA receptor modulators that may compensate for the effect of loss-of-function disease-associated GRIN mutations.
Kysilov B; Hrcka Krausova B; Vyklicky V; Smejkalova T; Korinek M; Horak M; Chodounska H; Kudova E; Cerny J; Vyklicky L
Br J Pharmacol; 2022 Aug; 179(15):3970-3990. PubMed ID: 35318645
[TBL] [Abstract][Full Text] [Related]
7. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
[No Abstract] [Full Text] [Related]
8. Neuroactive Steroid
La DS; Salituro FG; Martinez Botella G; Griffin AM; Bai Z; Ackley MA; Dai J; Doherty JJ; Harrison BL; Hoffmann EC; Kazdoba TM; Lewis MC; Quirk MC; Robichaud AJ
J Med Chem; 2019 Aug; 62(16):7526-7542. PubMed ID: 31390523
[TBL] [Abstract][Full Text] [Related]
9. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.
Li J; Zhang J; Tang W; Mizu RK; Kusumoto H; XiangWei W; Xu Y; Chen W; Amin JB; Hu C; Kannan V; Keller SR; Wilcox WR; Lemke JR; Myers SJ; Swanger SA; Wollmuth LP; Petrovski S; Traynelis SF; Yuan H
Hum Mutat; 2019 Dec; 40(12):2393-2413. PubMed ID: 31429998
[TBL] [Abstract][Full Text] [Related]
10. Endogenous 24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices.
Sun MY; Izumi Y; Benz A; Zorumski CF; Mennerick S
J Neurophysiol; 2016 Mar; 115(3):1263-72. PubMed ID: 26745248
[TBL] [Abstract][Full Text] [Related]
11. An Integrated Approach for Screening and Identification of Positive Allosteric Modulators of N-Methyl-D-Aspartate Receptors.
Jambrina E; Cerne R; Smith E; Scampavia L; Cuadrado M; Findlay J; Krambis MJ; Wakulchik M; Chase P; Brunavs M; Burris KD; Gallagher P; Spicer TP; Ursu D
J Biomol Screen; 2016 Jun; 21(5):468-79. PubMed ID: 26838761
[TBL] [Abstract][Full Text] [Related]
12. SAGE-718: A First-in-Class
Hill MD; Blanco MJ; Salituro FG; Bai Z; Beckley JT; Ackley MA; Dai J; Doherty JJ; Harrison BL; Hoffmann EC; Kazdoba TM; Lanzetta D; Lewis M; Quirk MC; Robichaud AJ
J Med Chem; 2022 Jul; 65(13):9063-9075. PubMed ID: 35785990
[No Abstract] [Full Text] [Related]
13. Disease-associated nonsense and frame-shift variants resulting in the truncation of the GluN2A or GluN2B C-terminal domain decrease NMDAR surface expression and reduce potentiating effects of neurosteroids.
Kysilov B; Kuchtiak V; Hrcka Krausova B; Balik A; Korinek M; Fili K; Dobrovolski M; Abramova V; Chodounska H; Kudova E; Bozikova P; Cerny J; Smejkalova T; Vyklicky L
Cell Mol Life Sci; 2024 Jan; 81(1):36. PubMed ID: 38214768
[TBL] [Abstract][Full Text] [Related]
14. Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators.
Yao L; Zhou Q
Neural Plast; 2017; 2017():2875904. PubMed ID: 28163934
[TBL] [Abstract][Full Text] [Related]
15. Positive allosteric modulation of NMDA receptors: mechanisms, physiological impact and therapeutic potential.
Geoffroy C; Paoletti P; Mony L
J Physiol; 2022 Jan; 600(2):233-259. PubMed ID: 34339523
[TBL] [Abstract][Full Text] [Related]
16. Allosteric modulators of NMDA receptors: multiple sites and mechanisms.
Zhu S; Paoletti P
Curr Opin Pharmacol; 2015 Feb; 20():14-23. PubMed ID: 25462287
[TBL] [Abstract][Full Text] [Related]
17. Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of
Strong KL; Epplin MP; Ogden KK; Burger PB; Kaiser TM; Wilding TJ; Kusumoto H; Camp CR; Shaulsky G; Bhattacharya S; Perszyk RE; Menaldino DS; McDaniel MJ; Zhang J; Le P; Banke TG; Hansen KB; Huettner JE; Liotta DC; Traynelis SF
ACS Chem Neurosci; 2021 Jan; 12(1):79-98. PubMed ID: 33326224
[No Abstract] [Full Text] [Related]
18. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.
Mony L; Kew JN; Gunthorpe MJ; Paoletti P
Br J Pharmacol; 2009 Aug; 157(8):1301-17. PubMed ID: 19594762
[TBL] [Abstract][Full Text] [Related]
19. Differential responses of disease-related GRIN variants located in pore-forming M2 domain of N-methyl-D-aspartate receptor to FDA-approved inhibitors.
Song R; Zhang J; Perszyk RE; Camp CR; Tang W; Kannan V; Li J; Xu Y; Chen J; Li Y; Liang SH; Traynelis SF; Yuan H
J Neurochem; 2023 Aug; ():. PubMed ID: 37649269
[TBL] [Abstract][Full Text] [Related]
20. Palmitoylation Controls NMDA Receptor Function and Steroid Sensitivity.
Hubalkova P; Ladislav M; Vyklicky V; Smejkalova T; Hrcka Krausova B; Kysilov B; Krusek J; Naimová Z; Korinek M; Chodounska H; Kudova E; Cerny J; Vyklicky L
J Neurosci; 2021 Mar; 41(10):2119-2134. PubMed ID: 33526476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
